Ignite Creation Date:
2024-05-05 @ 10:01 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00005652
Status:
COMPLETED
Last Update Posted:
2008-09-09
First Post:
2000-05-02
Brief Title:
Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura
Sponsor:
Organization:
Office of Rare Diseases ORD